Blume Capital Management’s Zimmer Biomet ZBH Stock Holding History

Blume Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10	Closed	-$1K	–	332
2022 Q3	$1K	Hold	10	–	–	﹤0.01%	306
2022 Q2	$1K	Sell	10 -100	-91%	-$11.9K	﹤0.01%	308
2022 Q1	$14K	Buy	110 +100	+1,000%	+$12.1K	﹤0.01%	242
2021 Q4	$1K	Hold	10	–	–	﹤0.01%	298
2021 Q3	$1K	Sell	10 -21	-68%	-$3.09K	﹤0.01%	299
2021 Q2	$5K	Sell	31 -135	-81%	-$21.9K	﹤0.01%	260
2021 Q1	$26K	Buy	+166	New	+$25.7K	0.01%	191
2018 Q2	–	Sell	-155	Closed	-$16K	–	226
2018 Q1	$16K	Buy	+155	New	+$18K	0.01%	163

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Blume Capital Management's ZBH Position: Q4 2022 in Review

Blume Capital Management sold out of Zimmer Biomet (ZBH) in Q4 2022, closing a stake of 10 shares — an estimated $1K sold.

Blume Capital Management first reported a position in ZBH in Q1 2018 and held it in 8 quarters. The position peaked at $26K in Q1 2021. 977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.

Blume Capital Management reported no remaining Zimmer Biomet position as of Q4 2022 after selling out during the quarter.
Blume Capital Management sold 10 Zimmer Biomet shares in Q4 2022, an estimated $1K.
Blume Capital Management first reported a position in Zimmer Biomet in Q1 2018 and held it in 8 quarters.
Blume Capital Management's Zimmer Biomet position peaked at $26K in Q1 2021.
977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.

Based on Blume Capital Management's 13F filing for Q4 2022, filed 8 Feb 2023.